187 related articles for article (PubMed ID: 8013757)
1. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients.
Rabini RA; Galassi R; Fumelli P; Dousset N; Solera ML; Valdiguie P; Curatola G; Ferretti G; Taus M; Mazzanti L
Diabetes; 1994 Jul; 43(7):915-9. PubMed ID: 8013757
[TBL] [Abstract][Full Text] [Related]
2. Reduced lecithin: cholesterol acyltransferase (LCAT) and Na+, K+, ATPase activity in diabetic patients.
Kiziltunç A; Akçay F; Polat F; Kuşkay S; Sahin YN
Clin Biochem; 1997 Mar; 30(2):177-82. PubMed ID: 9127701
[TBL] [Abstract][Full Text] [Related]
3. Modifications induced by plasma from insulin-dependent diabetic patients and by lysophosphatidylcholine on human Na+,K(+)-adenosine triphosphatase.
Rabini RA; Fumelli P; Zolese G; Amler E; Salvolini E; Staffolani R; Cester N; Mazzanti L
J Clin Endocrinol Metab; 1998 Jul; 83(7):2405-10. PubMed ID: 9661619
[TBL] [Abstract][Full Text] [Related]
4. Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients.
Rabini RA; Staffolani R; Fumelli P; Mutus B; Curatola G; Mazzanti L
Diabetologia; 1998 Jan; 41(1):101-4. PubMed ID: 9498637
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.
De La Tour DD; Raccah D; Jannot MF; Coste T; Rougerie C; Vague P
Diabetologia; 1998 Sep; 41(9):1080-4. PubMed ID: 9754827
[TBL] [Abstract][Full Text] [Related]
6. Sialic acid, diabetes, and aging: a study on the erythrocyte membrane.
Mazzanti L; Rabini RA; Salvolini E; Tesei M; Martarelli D; Venerando B; Curatola G
Metabolism; 1997 Jan; 46(1):59-61. PubMed ID: 9005970
[TBL] [Abstract][Full Text] [Related]
7. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
Mimura M; Makino H; Kanatsuka A; Yoshida S
Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
[TBL] [Abstract][Full Text] [Related]
8. Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.
Finotti P; Palatini P
Diabetologia; 1986 Sep; 29(9):623-8. PubMed ID: 3025045
[TBL] [Abstract][Full Text] [Related]
9. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
10. Altered cellular Ca2+ and Na+ transport in diabetes mellitus.
Mazzanti L; Rabini RA; Faloia E; Fumelli P; Bertoli E; De Pirro R
Diabetes; 1990 Jul; 39(7):850-4. PubMed ID: 2162303
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.
Raccah D; Fabreguetts C; Azulay JP; Vague P
Diabetes Care; 1996 Jun; 19(6):564-8. PubMed ID: 8725852
[TBL] [Abstract][Full Text] [Related]
12. Changes in Na,K-adenosine triphosphatase (ATPase) concentration and Na,K-ATPase-dependent adenosine triphosphate turnover in human erythrocytes in diabetes.
Garner MH
Metabolism; 1996 Aug; 45(8):927-34. PubMed ID: 8769346
[TBL] [Abstract][Full Text] [Related]
13. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus.
Jannot MF; Raccah D; Dufayet de la Tour D; Coste T; Gouvernet J; Vague P
Diabetes Metab; 1999 Mar; 25(1):35-42. PubMed ID: 10335422
[TBL] [Abstract][Full Text] [Related]
14. Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
Vague P; Dufayet D; Coste T; Moriscot C; Jannot MF; Raccah D
Diabetologia; 1997 May; 40(5):506-11. PubMed ID: 9165217
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Na+/K(+)-ATPase activity and fluidity of erythrocyte membranes from relatives of insulin dependent diabetic patients.
Rabini RA; Galassi R; Staffolani R; Vasta M; Fumelli P; Mazzanti L
Diabetes Res; 1993; 22(1):33-40. PubMed ID: 8200183
[TBL] [Abstract][Full Text] [Related]
16. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
17. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of sodium and potassium pump activity and number in diabetic erythrocytes.
Nagamatsu S; Inoue N; Murakawa S; Matsui H
Acta Endocrinol (Copenh); 1986 Jan; 111(1):69-74. PubMed ID: 3004092
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]